LARIMAR THERAPEUTICS, INC. Stock Issued During Period, Shares, New Issues
LARIMAR THERAPEUTICS, INC. (LRMR) had Stock Issued During Period, Shares, New Issues of 6.90 million shares as of 2014-06-24, per its 10-Q filed 2014-11-13.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2014-11-13
- 2014-06-24: Stock Issued During Period, Shares, New Issues 6.90M shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2014-06-24 | 6.90M shares 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |